JP2004511523A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004511523A5 JP2004511523A5 JP2002535670A JP2002535670A JP2004511523A5 JP 2004511523 A5 JP2004511523 A5 JP 2004511523A5 JP 2002535670 A JP2002535670 A JP 2002535670A JP 2002535670 A JP2002535670 A JP 2002535670A JP 2004511523 A5 JP2004511523 A5 JP 2004511523A5
- Authority
- JP
- Japan
- Prior art keywords
- hormone
- cancer
- antiprogestin
- affected
- ability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000000708 anti-progestin effect Effects 0.000 description 2
- 239000003418 antiprogestin Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- YVNHODBGZHYTLZ-UUGBVKLGSA-N C[C@](C[C@@H]1c2ccc(C=O)cc2)([C@@H](CC2)[C@H](CC3)C1=C(CC1)C3=CC1=O)[C@@]2(C(C(F)(F)F)(C=C)F)O Chemical compound C[C@](C[C@@H]1c2ccc(C=O)cc2)([C@@H](CC2)[C@H](CC3)C1=C(CC1)C3=CC1=O)[C@@]2(C(C(F)(F)F)(C=C)F)O YVNHODBGZHYTLZ-UUGBVKLGSA-N 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 230000002513 anti-ovulatory effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24099100P | 2000-10-18 | 2000-10-18 | |
| EP00250342 | 2000-10-18 | ||
| PCT/EP2001/012006 WO2002032432A1 (en) | 2000-10-18 | 2001-10-17 | Use of antiprogestins for the induction of apoptosis in a cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004511523A JP2004511523A (ja) | 2004-04-15 |
| JP2004511523A5 true JP2004511523A5 (enExample) | 2009-01-29 |
Family
ID=26072952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002535670A Pending JP2004511523A (ja) | 2000-10-18 | 2001-10-17 | 細胞におけるアポトシスの誘発のための抗黄体ホルモンの使用 |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1326617B9 (enExample) |
| JP (1) | JP2004511523A (enExample) |
| KR (1) | KR100668024B1 (enExample) |
| CN (1) | CN1209111C (enExample) |
| AT (1) | ATE334683T1 (enExample) |
| AU (2) | AU2361902A (enExample) |
| BG (1) | BG107744A (enExample) |
| BR (1) | BR0114696A (enExample) |
| CA (1) | CA2423020C (enExample) |
| CY (1) | CY1105745T1 (enExample) |
| CZ (1) | CZ299823B6 (enExample) |
| DE (1) | DE60121980T2 (enExample) |
| DK (1) | DK1326617T3 (enExample) |
| EA (1) | EA010593B1 (enExample) |
| EE (1) | EE200300157A (enExample) |
| ES (1) | ES2269492T3 (enExample) |
| HR (1) | HRP20030388A2 (enExample) |
| HU (1) | HUP0301433A3 (enExample) |
| IL (2) | IL154976A0 (enExample) |
| MX (1) | MXPA03002955A (enExample) |
| NO (1) | NO20031741L (enExample) |
| NZ (1) | NZ538347A (enExample) |
| PL (1) | PL360157A1 (enExample) |
| PT (1) | PT1326617E (enExample) |
| SI (1) | SI1326617T1 (enExample) |
| SK (1) | SK4702003A3 (enExample) |
| UA (1) | UA76729C2 (enExample) |
| WO (1) | WO2002032432A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY27301A1 (es) * | 2001-05-25 | 2003-02-28 | Schering Ag | Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata |
| US20040242551A1 (en) * | 2003-05-28 | 2004-12-02 | Schering Ag | Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| CA2683517A1 (en) * | 2007-04-23 | 2008-10-30 | Bayer Schering Pharma Aktiengesellschaft | Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases |
| US20080268041A1 (en) * | 2007-04-23 | 2008-10-30 | Jens Hoffmann | Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases |
| CA2683809A1 (en) * | 2007-04-23 | 2008-10-30 | Bayer Schering Pharma Aktiengesellschaft | Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen |
| GB0718167D0 (en) | 2007-09-18 | 2007-10-31 | Cancer Rec Tech Ltd | Cancer marker and therapeutic target |
| AU2012318618B2 (en) * | 2011-10-04 | 2017-01-12 | Invivis Pharmaceuticals Inc. | Methods and systems for identifying and treating anti-progestin sensitive tumors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
-
2001
- 2001-10-17 SK SK470-2003A patent/SK4702003A3/sk not_active Application Discontinuation
- 2001-10-17 DE DE60121980T patent/DE60121980T2/de not_active Expired - Fee Related
- 2001-10-17 AT AT01987669T patent/ATE334683T1/de not_active IP Right Cessation
- 2001-10-17 NZ NZ538347A patent/NZ538347A/en unknown
- 2001-10-17 KR KR1020037005360A patent/KR100668024B1/ko not_active Expired - Fee Related
- 2001-10-17 EP EP01987669A patent/EP1326617B9/en not_active Expired - Lifetime
- 2001-10-17 PT PT01987669T patent/PT1326617E/pt unknown
- 2001-10-17 EA EA200300479A patent/EA010593B1/ru not_active IP Right Cessation
- 2001-10-17 EE EEP200300157A patent/EE200300157A/xx unknown
- 2001-10-17 AU AU2361902A patent/AU2361902A/xx active Pending
- 2001-10-17 MX MXPA03002955A patent/MXPA03002955A/es active IP Right Grant
- 2001-10-17 CA CA002423020A patent/CA2423020C/en not_active Expired - Fee Related
- 2001-10-17 JP JP2002535670A patent/JP2004511523A/ja active Pending
- 2001-10-17 ES ES01987669T patent/ES2269492T3/es not_active Expired - Lifetime
- 2001-10-17 WO PCT/EP2001/012006 patent/WO2002032432A1/en not_active Ceased
- 2001-10-17 HR HR20030388A patent/HRP20030388A2/hr not_active Application Discontinuation
- 2001-10-17 UA UA2003054311A patent/UA76729C2/uk unknown
- 2001-10-17 CN CNB018175694A patent/CN1209111C/zh not_active Expired - Fee Related
- 2001-10-17 AU AU2002223619A patent/AU2002223619B2/en not_active Ceased
- 2001-10-17 BR BR0114696-3A patent/BR0114696A/pt not_active Application Discontinuation
- 2001-10-17 HU HU0301433A patent/HUP0301433A3/hu unknown
- 2001-10-17 SI SI200130648T patent/SI1326617T1/sl unknown
- 2001-10-17 PL PL01360157A patent/PL360157A1/xx not_active Application Discontinuation
- 2001-10-17 CZ CZ20031073A patent/CZ299823B6/cs not_active IP Right Cessation
- 2001-10-17 IL IL15497601A patent/IL154976A0/xx active IP Right Grant
- 2001-10-17 DK DK01987669T patent/DK1326617T3/da active
-
2003
- 2003-03-18 IL IL154976A patent/IL154976A/en not_active IP Right Cessation
- 2003-04-15 NO NO20031741A patent/NO20031741L/no not_active Application Discontinuation
- 2003-04-18 BG BG107744A patent/BG107744A/bg unknown
-
2006
- 2006-11-01 CY CY20061101564T patent/CY1105745T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004511522A5 (enExample) | ||
| DE60115274D1 (de) | Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen | |
| DE60324431D1 (de) | Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata- oder gebahrmutterkrebs | |
| CL2003002293A1 (es) | Compuestos derivados de indazol; su composicion farmaceutica; su uso en el tratamiento de hipertension ocular. | |
| DE50205466D1 (de) | Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen | |
| HUP0203050A2 (hu) | Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények | |
| EE200300157A (et) | Antiprogestiinide kasutamine apoptoosi esilekutsumiseks rakus | |
| EA200501739A1 (ru) | Композиция, содержащая антагонисты рецептора прогестерона и чистые антиэстрогены, предназначенные для профилактики и лечения гормонзависимых заболеваний | |
| YU29903A (sh) | Upotreba antiprogestina za indukciju apoptoze u ćeliji | |
| GB0229022D0 (en) | Organic Compounds | |
| RU2004132305A (ru) | Способ и средство для лечения доброкачественных гиперпластических процессов эндометрия | |
| RU2004116167A (ru) | Способ повышения эффективности лечения бесплодия, вызванного малыми формами внешнего генитального эндометриоза | |
| EA200300480A1 (ru) | Применение антипрогестинов для профилактики и лечения гормонозависимых заболеваний | |
| RU2001130961A (ru) | Способ лечения подагры с помощью плазмосорбции | |
| IS7338A (is) | Tibólón í meðhöndlun á kvillum tengdum inngjöf á lyfjum sem koma í veg fyrir efnasamtengingu á innrænu estrógeni | |
| PL356767A1 (pl) | Zastosowanie hormonów płciowych do wytwarzania donosowej kompozycji farmaceutycznej, korzystnej do leczenia niepożądanych krwawień z macicy | |
| TW200733955A (en) | Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases | |
| RU2002120932A (ru) | Способ лечения эрозивных поражений гастродуоденальной зоны, резистентных к обычной терапии, у больных бронхиальной астмой | |
| RU2002133272A (ru) | Способ лечения спаечной болезни | |
| NO20013901L (no) | Umettede kolestanderivater og deres anvendelse for fremstilling av meioseregulerende medikamenter | |
| RU2005106445A (ru) | Способ лечения рецидивирующих остроконечных кондилом |